Aquestive Therapeutics (AQST) Assets Average (2018 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Assets Average of $150.8 million for Q1 2026, up 48.07% year-over-year from $101.8 million in Q1 2025, and down 6.92% quarter-over-quarter from $162.0 million in Q4 2025.
Aquestive Therapeutics (AQST) Assets Average (2018 - 2026) Analysis & Trends
Aquestive Therapeutics' Assets Average history runs 9 years deep, the most recent figure standing at $150.8 million for Q1 2026.
- In Q1 2026, Assets Average rose 48.07% year-over-year to $150.8 million; the TTM figure through Mar 2026 stood at $150.8 million (up 48.07% YoY), while the FY2025 annual figure was $130.9 million, up 64.85% from the prior year.
- Assets Average for Q1 2026 stood at $150.8 million, down from $162.0 million in the prior quarter.
- The five-year high for Assets Average was $162.0 million in Q4 2025, with the low at $54.1 million in Q3 2022.
- The 5-year median for Assets Average is $93.5 million (2024), against an average of $90.4 million.
- The sharpest annual moves came in 2024 and 2025: Assets Average soared 108.94% in 2024, then fell 20.72% in 2025.
- Aquestive Therapeutics' Assets Average stood at $54.5 million in 2022, then advanced by 7.3% to $58.4 million in 2023, then jumped by 80.88% to $105.7 million in 2024, then jumped by 53.27% to $162.0 million in 2025, then retreated by 6.92% to $150.8 million in 2026.
- Business Quant data shows AQST's Assets Average at $150.8 million in Q1 2026, $162.0 million in Q4 2025, and $128.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | Aquestive Therapeutics | 552.47 Mn | 552.47 Mn | 9.80 Mn | 136.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 136.61 Mn |
| Mar 31, 2026 | 150.78 Mn |
| Dec 31, 2025 | 161.99 Mn |
| Sep 30, 2025 | 128.63 Mn |
| Jun 30, 2025 | 97.97 Mn |
| Mar 31, 2025 | 101.83 Mn |
| Dec 31, 2024 | 105.69 Mn |
| Sep 30, 2024 | 113.78 Mn |
| Jun 30, 2024 | 123.56 Mn |
| Mar 31, 2024 | 93.47 Mn |
| Dec 31, 2023 | 58.43 Mn |
| Sep 30, 2023 | 58.22 Mn |
| Jun 30, 2023 | 59.14 Mn |
| Mar 31, 2023 | 59.18 Mn |
| Dec 31, 2022 | 54.46 Mn |
| Sep 30, 2022 | 54.08 Mn |
| Jun 30, 2022 | 56.42 Mn |
| Mar 31, 2022 | 59.26 Mn |
| Dec 31, 2021 | 63.64 Mn |
| Sep 30, 2021 | 66.08 Mn |